Shire is to acquire rare disease company ViroPharma for $4.2 billion in a strategic move to boost its orphan drug portfolio. ViroPharma is a high growth, rare disease biopharma company ...
ViroPharma, Washington U., Find Drug To Treat Pestivirus Livestock Plagues - With Hepatitis C Kicker
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on ...
Cost savings have resulted in profitability gains despite mixed divisional performance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback